Cryptococcus neoformans and Cryptococcus gattii genes preferentially expressed during rat macrophage infection

Medical Mycology

Volumn 48, Issue 7, 2010, Pages 932-941

  Goulart, Letcia ^a   Silva, Lvia Kmetzsch Rosa E ^a   Chiapello, Laura ^b   Silveira, Carolina ^a   Crestani, Juliana ^a   Masih, Diana ^b   Vainstein, Marilene Henning ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Cryptococcus gattii; Cryptococcus neoformans; Macrophages; RDA

Indexed keywords

ABC TRANSPORTER; CHAPERONE; HISTONE; INOSITOL; MONOSACCHARIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE;

ANIMAL CELL; ARTICLE; BREATHING; CARBOHYDRATE METABOLISM; CELL GROWTH; CONTROLLED STUDY; CRYPTOCOCCUS GATTII; CRYPTOCOCCUS NEOFORMANS; ENZYME ACTIVITY; ENZYME INDUCTION; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; INFECTION; INTRACELLULAR SIGNALING; INTRACELLULAR SPACE; INTRACELLULAR TRANSPORT; MALE; MICROTUBULE; NITROGEN METABOLISM; NONHUMAN; NUCLEOTIDE SEQUENCE; PERITONEUM MACROPHAGE; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN METHYLATION; PURINE METABOLISM; RAT; RIBOSOME; STRESS; UPREGULATION;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CRYPTOCOCCOSIS; CRYPTOCOCCUS GATTII; CRYPTOCOCCUS NEOFORMANS; FUNGAL PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, FUNGAL; HOST-PATHOGEN INTERACTIONS; HUMANS; MACROPHAGES, PERITONEAL; MALE; OXIDOREDUCTASES; RATS; RATS, WISTAR; VIRULENCE;

CRYPTOCOCCUS GATTII; FILOBASIDIELLA NEOFORMANS; RATTUS;

EID: 77957734231     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693781003677494     Document Type: Article

References (56)

1. Lin X, Heitman J. The biology of the Cryptococcus neoformans species complex. Annu Rev Microbiol 2006; 60: 69-105.
2. Bovers M, Hagen F, Boekhout T. Diversity of the Cryptococcus neoformans-Cryptococcus gattii species complex. Rev Iberoam Micol 2008; 25: 4-12.
3. Steenbergen JN, Casadevall A. The origin and maintenance of viru-lence for the human pathogenic fungus Cryptococcus neoformans. Microbes Infect 2003; 5: 667-675.
4. Idnurm A, Bahn YS, Nielsen K, et al. Deciphering the model patho-genic fungus Cryptococcus neoformans. Nat Rev Microbiol 2005; 3: 753-764.
5. Drevets DA, Leenen PJ. Leukocyte-facilitated entry of intracellular pathogens into the central nervous system. Microbes Infect 2000; 2: 1609-1618.
6. Feldmesser M, Kress Y, Novikoff P, Casadevall A. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmo-nary infection. Infect Immun 2000; 68: 4225-4237.
7. Luberto C, Martinez-Mariño B, Taraskiewicz D, et al. Identif cation of App1 as a regulator of phagocytosis and virulence of Cryptococcus neoformans. J Clin Invest 2003; 112: 1080-1094.
8. Feldmesser M, Tucker S, Casadevall A. Intracellular parasitism of macrophages by Cryptococcus neoformans. Trends Microbiol 2001; 9: 273-278.
9. Alvarez M, Saylor C, Casadevall A. Antibody action after phagocy-tosis promotes Cryptococcus neoformans and Cryptococcus gattii macrophage exocytosis with biof lm-like microcolony formation. Cell Microbiol 2008; 10: 1622-1633.
10. Levitz SM, Nong SH, Seetoo KF, et al. Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages. Infect Immun 1999; 67: 885-890.
11. Tucker SC, Casadevall A. Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm. Proc Natl Acad Sci USA 2002; 5: 3165-3170.
12. Alvarez M, Casadevall A. Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages. Curr Biol 2006; 7: 2161-2165.
13. Ma H, Croudace JE, Lammas DA, May RC. Expulsion of live patho-genic yeast by macrophages. Curr Biol 2006; 7: 2156-2160.
14. Luo Y, Alvarez M, Xia L, Casadevall A. The outcome of phagocytic cell division with infectious cargo depends on single phagosome formation. PLoS ONE 2008; 16: 3219.
15. Steenbergen JN, Shuman HA, Casadevall A. Cryptococcus neo-formans interactions with amoebae suggests an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proc Natl Acad Sci USA 2001; 18: 15245-15250.
16. Del Poeta M. Role of phagocytosis in the virulence of Cryptococcus neoformans. Eukaryot Cell 2004; 3: 1067-1075.
17. Hubank M, Schatz DG. Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res 1994; 22:5640-5648.
18. Rosa E Silva LK, Staats CC, Goulart LS, et al Identif cation of novel temperature-regulated genes in the human pathogen Cryptococcus neoformans using representational difference analysis. Res Microbiol 2008; 159: 221-229.
19. Chiapello LS, Baronetti JL, Aoki MP, Rubinstein HR, Masih DT. Immunosuppression, interleukin-10 synthesis and apoptosis are induced in rats inoculated with Cryptococcus neoformans glucuron-oxylomannan. Immunology 2004; 113: 392-400.
20. Mukherjee J, Pirofski L, Scharff MD, Casadevall A. Antibody-mediated protection in mice with lethal intracerebral Crypto-coccus neoformans infection. Proc Natl Acad Sci USA 1993; 90: 3636-3640.
21. Dutra V, Nakazato L, Broetto L, et al. Application of represen-tational difference analysis to identify sequence tags expressed by Metarhizium anisopliae during the infection process of the tick Boophilus microplus cuticle. Res Microbiol 2004; 155: 245-251.
22. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 432-440.
23. Gross NT, Nessa K, Camner P, Chinchilla M, Jarstrand C. Interaction between Cryptococcus neoformans and alveolar macrophages. J Med Vet Mycol 1997; 35: 263-269.
24. Nessa K, Gross NT, Jarstrand C, Johansson A, Camner P. In vivo interaction between alveolar macrophages and Cryptococcus neo-formans. Mycopathologia 1997; 1: 1-7.
25. Alvarez M, Saylor C, Casadevall A. Antibody action after phagocy-tosis promotes Cryptococcus neoformans and Cryptococcus gattii macrophage exocytosis with biof lm-like microcolony formation. Cell Microbiol 2008; 10: 1622-1633.
26. Bailão AM, Schrank A, Borges CL, et al. Differential gene expres-sion by Paracoccidioides brasiliensis in host interaction condi-tions: representational difference analysis identif es candidate genes associated with fungal pathogenesis. Microbes Infect 2006; 8: 2686-2697.
27. Baeza LC, Bailão AM, Borges CL, et al. cDNA representational difference analysis used in the identif cation of genes expressed by Trichophyton rubrum during contact with keratin. Microbes Infect 2007; 9: 1415-1421.
28. Rodrigues ML, Nimrichter L, Oliveira DL, et al. Vesicular polysac-charide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport. Eukaryot Cell 2007; 6:48-59.
29. Yoneda A, Doering TL. An eukaryotic capsular polysaccharide is synthesized intracellularly and secreted via exocytosis. Mol Biol Cell 2006; 17:5131-5140.
30. Boman AL, Zhang C, Zhu X, Kahn RA. A family of ADP-ribosylation factor effectors that can alter membrane transport through the trans-Golgi. Mol Biol Cell 2000; 11: 1241-1255.
31. Stearns T, Kahn RA, Botstein D, Hoyt MA. ADP ribosylation factor is an essential protein in Saccharomyces cerevisiae and is encoded by two genes. Mol Cell Biol 1990; 10: 6690-6699.
32. Burke MA, Ardehali H. Mitochondrial ATP-binding cassette proteins. Transl Res 2007; 150: 73-80.
33. Sanguinetti M, Posteraro B, La Sorda M, et al. Role of AFR1, an ABC transporter-encoding gene, in the in vivo response to f uconazole and virulence of Cryptococcus neoformans. Infect Immun 2006; 74: 1352-1359.
34. Fan W, Kraus PR, Boily MJ, Heitman J. Cryptococcus neoformans gene expression during murine macrophage infection. Eukaryot Cell 2005; 4: 1420-1433.
35. Theiss S, Kretschmar M, Nichterlein T, et al. Functional analy-sis of a vacuolar ABC transporter in wild-type Candida albicans reveals its involvement in virulence. Mol Microbiol 2002; 43: 571-584.
36. Caplan AJ, Mandal AK, Theodoraki MA. Molecular chaperones and protein kinase quality control. Trends Cell Biol 2007; 17: 87-92.
37. Burnie JP, Carter TL, Hodgetts SJ, Matthews RC. Fungal heat-shock proteins in human disease. FEMS Microbiol Rev 2006; 30: 53-88.
38. De Matteis MA, Di Campli A, Godi A. The role of the phospho-inositides at the Golgi complex. Biochim Biophys Acta 2005; 10: 396-405.
39. Odorizzi G, Babst M, Emr SD. Phosphoinositide signaling and the regulation of membrane traff cking in yeast. Trends Biochem Sci 2000; 25:229-235.
40. Newpher TM, Idrissi FZ, Geli MI, Lemmon SK. Novel function of clathrin light chain in promoting endocytic vesicle formation. Mol Biol Cell 2006; 17: 4343-4352.
41. Maldonado-Báez L, Dores MR, Perkins EM, et al. Endocytic adap-tors: recruiters, coordinators and regulators. Mol Biol Cell 2008; 19: 2936-2948.
42. Nickel W, Wieland FT Biogenesis of COPI-coated transport vesicles. FEBS Lett 1999; 25: 395-400.
43. Kielen N, Kloepper TH, Fasshauer D. Phylogeny of the SNARE vesicle fusion machinery yields insights into the conservation of the secretory pathway in fungi. BMC Evol Biol 2009; 9: 19.
44. Rodrigues ML, Nakayasu ES, Oliveira DL, et al. Extracellular vesi-cles produced by Cryptococcus neoformans contain protein compo-nents associated with virulence. Eukary Cell 2008; 7: 58-67.
45. Nosanchuk JD, Nimrichter L, Casadevall A, Rodrigues ML. A role for vesicular transport of macromolecules across cell walls in fungal pathogenesis. Commun Integrat Biol 2008; 1: 37-39.
46. Kraus PR, Fox DS, Cox GM, Heitman J. The Cryptococcus neofor-mans MAP kinase Mpk1 regulates cell integrity in response to anti-fungal drugs and loss of calcineurin function. Mol Microbiol 2003; 48: 1377-1387.
47. Román E, Arana DM, Nombela C, Alonso-Monge R, Pla J. MAP kinase pathways as regulators of fungal virulence. Trends Microbiol 2007; 15: 181-190.
48. Elbein AD, Pan YT, Pastuszak I, Carroll D. New insights on trehalose: a multifunctional molecule. Glycobiology 2003; 13: 17-27.
49. Petzold EW, Himmelreich U, Mylonakis E, et al. Characterization and regulation of the trehalose synthesis pathway and its importance in the pathogenicity of Cryptococcus neoformans. Infect Immun 2006; 74:5877-5887.
50. Martínez-Esparza M, Aguinaga A, González-Párraga P, et al. Role of trehalose in resistance to macrophage killing: study with a tps1/tps1 trehalose-def cient mutant of Candida albicans. Clin Microbiol Infect 2007; 13:384-394.
51. Estruch F. Stress-controlled transcription factors, stress-induced genes and stress tolerance in budding yeast. FEMS Microbiol Rev 2000; 24:469-486.
52. Chiapello LS, Baronetti JL, Garro AP, Spesso MF, Masih DT. Cryptococcus neoformans glucuronoxylomannan induces macro-phage apoptosis mediated by nitric oxide in a caspase-independent pathway. Int Immunol 2008; 20: 1527-1541.
53. Ma H, Hagen F, Stekel DJ, et al. The fatal fungal outbreak on Vancouver Island is characterized by enhanced intracellular parasitism driven by mitochondrial regulation. Proc Natl Acad Sci USA 2009; 106: 12980-12985.
54. Ma H, May RC. Virulence in Cryptococcus species. Adv Appl Microbiol 2009; 67: 131-190.
55. Ludin KM, Hilti N, Schweingruber ME. Schizosaccharomyces pombe Rds1, an adenine-repressible gene regulated by glucose, ammonium, phosphate, carbon dioxide and temperature. Mol Gen Genet 1995; 30: 439-445.
56. Kraus PR, Boily MJ, Giles SS, et al. Identif cation of Cryptococcus neoformans temperature-regulated genes with a genomic-DNA microarray Eukaryot Cell 2004; 3: 1249-1260.